CINTAS CORP (CTAS) Most Active Options

The 25 most actively traded CINTAS CORP (CTAS) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Oct 12, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$205.21
52-week range
$163.57 – $217.13
ATM IV (30d)
22.3%
IV rank
9 / 100
Low
Expected move
±$7.93 (±3.9%)
Put/call OI
0.83
Max pain
$190
↓ 7.4% below close
Next earnings
Dec 9, 2026

Chat with OptAI about CTAS


Most Active CTAS Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
CTAS $200 call Nov 20, 2026 39d $9.72 21.9% 4 0.67 624 344 55.7× avg
CTAS $220 call Nov 20, 2026 39d $0.60 23.7% 11 0.21 574 89 6.7× avg
CTAS $220 call Dec 18, 2026 67d $4.10 24.8% 15 0.29 191 57 4.3× avg
CTAS $210 call Dec 18, 2026 67d $7.70 27.4% 62 0.46 2,504 52 2.2× avg
CTAS $210 call Nov 20, 2026 39d $4.42 21.0% 0 0.40 373 45 1.9× avg
CTAS $210 call Oct 16, 2026 4d $0.75 30.4% 19 0.24 304 28 1.4× avg
CTAS $190 put Nov 20, 2026 39d $1.30 24.3% 11 -0.15 134 23 3.5× avg
CTAS $210 put Dec 18, 2026 67d $10.40 25.1% 5 -0.54 29 17 2.9× avg
CTAS $200 call Oct 16, 2026 4d $6.55 34.5% 51 0.77 572 15 3.9× avg
CTAS $200 call Jan 15, 2027 95d $14.90 25.8% 31 0.63 130 14 28.5× avg
CTAS $200 put Nov 20, 2026 39d $3.55 23.0% 5 -0.34 196 11 1.2× avg
CTAS $200 call Oct 23, 2026 11d $6.60 25.8% 52 0.73 5 11 4.2× avg
CTAS $202.5 put Oct 16, 2026 4d $1.60 23.8% 7 -0.29 14 10 1.1× avg
CTAS $185 put Oct 23, 2026 11d $0.10 36.4% 26 -0.05 17 9 3.0× avg
CTAS $230 call Oct 23, 2026 11d $0.15 36.3% 9 0.04 26 8 6.3× avg
CTAS $215 put Nov 6, 2026 25d $10.50 21.2% 47 -0.78 0 7 10.5× avg
CTAS $195 put Oct 30, 2026 18d $0.91 26.4% 24 -0.18 13 7 1.1× avg
CTAS $220 call Feb 19, 2027 130d $6.70 22.7% 0 0.36 4 6 4.3× avg
CTAS $180 put Nov 20, 2026 39d $0.64 28.0% 31 -0.06 1,360 6 0.9× avg
CTAS $190 put Dec 18, 2026 67d $2.95 25.1% 16 -0.20 116 6 0.9× avg
CTAS $200 call Oct 30, 2026 18d $7.50 29.1% 43 0.68 4 6 3.4× avg
CTAS $195 put Dec 18, 2026 67d $4.10 25.6% 32 -0.28 560 6 0.6× avg
CTAS $215 call Oct 16, 2026 4d $0.18 27.9% 4 0.06 254 5 0.8× avg
CTAS $205 call Oct 16, 2026 4d $2.55 25.9% 12 0.53 31 5 0.3× avg
CTAS $190 put Mar 19, 2027 158d $5.90 25.1% 5 -0.26 25 5 9.8× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active CTAS contract today is the $200 call expiring in 39 days, with 344 contracts traded. Calls dominate the most-active list (14 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on CTAS for free

Build multi-leg CTAS strategies, visualize payoffs, and scan the full US options universe with OptiView.

CTAS Options FAQ

Which CTAS option contract is most active today?

The most traded CTAS contract is the $200 call expiring Nov 20, 2026, with 344 contracts traded as of Oct 12, 2026.

How does OptiView rank the most active CTAS options?

The table lists the 25 CTAS contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.